SightfileU.S. market data from official filings

Companies › SANA

SANA BIOTECHNOLOGY INC (SANA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001770121 · EDGAR filings · Updated 2026-07-07

SANA BIOTECHNOLOGY INC (SANA) has reported institutional ownership of 59.0%, with 200 institutional managers holding positions valued at $472.6M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
59.0%
Institutional managers
200
Reported 13F value
$472.6M
Insider activity
22 trans.
$0 net flat
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SANA BIOTECHNOLOGY INC has 200 institutional holders and institutional ownership of 59.0%.

Insider activity

Insiders reported 22 transactions (0 buys, 0 sells) across 4 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-11 (recurring since 2025-03-17) — source filing. The authoritative details are those stated in the filing itself.

Related companies

MAPLIGHT THERAPEUTICS INC (MPLT) · BETA BIONICS INC (BBNX) · MINIMED GROUP INC (MMED) · 4D MOLECULAR THERAPEUTICS IN (FDMT) · BIOVENTUS (BVS) · AVALO THERAPEUTICS INC (AVTX)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-07.